✦ LIBER ✦

Could serum HBV DNA level in the early phase of acute hepatitis predict evolution to chronic HBV carriage?

✍ Scribed by Philippe Roingeard; Frédéric Dubois; Yannick Bacq; Francis Barin; Alain Goudeau

Book ID: 118567684
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 124 KB
Volume: 26
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(97)80267-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes of serum HBV-DNA in relation to

Changes of serum HBV-DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis

✍ Yun-Fan Liaw; Chia-Chu Pao; Chia-Ming Chu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

[480] LONGITUDINAL CHANGES IN SERUM HBV-

[480] LONGITUDINAL CHANGES IN SERUM HBV-DNA LEVELS DURING THE NATURAL COURSE OF HBeAg-NEGATIVE CHRONIC HEPATITIS B VIRUS (HBV) INFECTION

✍ G.V. Papatheodoridis; V. Sevastianos; H. Panopoulou; N. Chrysanthos; E. Hadziyan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 145 KB

496 Serum hepatitis B virus DNA level pr

496 Serum hepatitis B virus DNA level predicts the incidence of liver cirrhosis in persons chronically infected with HBV

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

The inverse association of serum HBV DNA

The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection

✍ Ashraf Mohamadkhani; Kourosh Sayemiri; Reza Ghanbari; Elham Elahi; Hossein Poust 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 647 KB

PP-095 Dynamics of serum HBV DNA levels

PP-095 Dynamics of serum HBV DNA levels and MELD scores in fatal acute-on-chronic hepatitis B liver failure

✍ J. Lai; D.-Y. Xie; T.-Y. Chong; Z.-G. Yao; Q.-W. Mo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Early on-treatment prediction of respons

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

✍ Vincent Rijckborst; Bettina E. Hansen; Yilmaz Cakaloglu; Peter Ferenci; Fehmi Ta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Ferenci is a consultant for, advises, is on the speakers' bureau of, and received grants from Roche. Dr. Janssen is a consultant for and received grants from Roche, Bristol-Myers Squibb, Schering-Plough, Novartis, and Gilead. Dr. Flisiak received grants from Roche.